🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Barbara White

Corbus Pharmaceuticals (United States)

ORCID: 0000-0003-4679-665X

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial”.

Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial

Journal of Investigative Dermatology(2022)10.1016/j.jid.2022.03.029

N/A

0.601DataRank · unranked

54 citations

Emily Z. Hejazi, S.M. Peña, Jessica S. Haber, Majid Zeidi, Nithin Reddy +10 more

OP0171 PHASE 3 TRIAL OF LENABASUM, A CB2 AGONIST, FOR THE TREATMENT OF DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (DCSSC)

Annals of the Rheumatic Diseases(2021)10.1136/annrheumdis-2021-eular.1795

N/A

0.373DataRank · unranked

11 citations

Masataka Kuwana, Dinesh Khanna, Laura K. Hummers, Tracy Frech, Wendy Stevens +13 more

Long-Term Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: Follow-Up Data from a 3-Year Open-Label Extension Study

JID Innovations(2024)10.1016/j.xjidi.2024.100311

N/A

0.297DataRank · unranked

6 citations

Geeta Ahuja, Laís Lopes Almeida Gomes, Joy Poroye, D Faden, Lillian Xie +4 more

Validation of Cutaneous Dermatomyositis Disease Area and Severity Index Activity Score and Other Efficacy Outcomes as Measures of Skin Disease in Dermatomyositis in the Lenabasum Phase 3 Trial

Journal of Investigative Dermatology(2023)10.1016/j.jid.2023.05.025

N/A

0DataRank · unranked

12 citations

Joshua Dan, Julianne Kleitsch, Barbara White, Victoria P. Werth, Rachita Pandya

Development and Evaluation of the Dermatomyositis Outcomes for Muscle and Skin as an Outcome Measure in Dermatomyositis Clinical Trials

JID Innovations(2024)10.1016/j.xjidi.2024.100337

N/A

0DataRank · unranked

4 citations

Joshua Dan, Julianne Kleitsch, Darosa Lim, Barbara White, Victoria P. Werth +1 more